{"id":929,"date":"2017-07-13T08:22:50","date_gmt":"2017-07-13T12:22:50","guid":{"rendered":"http:\/\/carolinaurologicresearchcenter.com\/?p=929"},"modified":"2017-07-13T08:24:25","modified_gmt":"2017-07-13T12:24:25","slug":"clinical-outcomes-androgen-signaling-directed-therapy-treatment-abiraterone-acetate-prednisone-patients-metastatic-castration-resistant-prostate-cancer-post-hoc","status":"publish","type":"post","link":"https:\/\/carolinaurologicresearchcenter.com\/clinical-outcomes-androgen-signaling-directed-therapy-treatment-abiraterone-acetate-prednisone-patients-metastatic-castration-resistant-prostate-cancer-post-hoc\/","title":{"rendered":"Clinical Outcomes from Androgen Signaling\u2013directed Therapy after Treatment with Abiraterone Acetate and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302. With Dr. Neal Shore"},"content":{"rendered":"<p><a href=\"https:\/\/carolinaurologicresearchcenter.com\/\/wp-content\/uploads\/Smith_Eur-Urol.2017.pdf\">Click here to read more.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Click here to read more.<\/p>\n","protected":false},"author":1,"featured_media":927,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"link","meta":{"ngg_post_thumbnail":0,"footnotes":""},"categories":[1],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Clinical Outcomes from Androgen Signaling\u2013directed Therapy after Treatment with Abiraterone Acetate and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302. With Dr. Neal Shore - Carolina Urologic Research Center - Myrtle Beach, SC<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/carolinaurologicresearchcenter.com\/clinical-outcomes-androgen-signaling-directed-therapy-treatment-abiraterone-acetate-prednisone-patients-metastatic-castration-resistant-prostate-cancer-post-hoc\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Clinical Outcomes from Androgen Signaling\u2013directed Therapy after Treatment with Abiraterone Acetate and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302. With Dr. Neal Shore - Carolina Urologic Research Center - Myrtle Beach, SC\" \/>\n<meta property=\"og:description\" content=\"Click here to read more.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/carolinaurologicresearchcenter.com\/clinical-outcomes-androgen-signaling-directed-therapy-treatment-abiraterone-acetate-prednisone-patients-metastatic-castration-resistant-prostate-cancer-post-hoc\/\" \/>\n<meta property=\"og:site_name\" content=\"Carolina Urologic Research Center - Myrtle Beach, SC\" \/>\n<meta property=\"article:published_time\" content=\"2017-07-13T12:22:50+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2017-07-13T12:24:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/carolinaurologicresearchcenter.com\/wp-content\/uploads\/7.13-Clinical-Outcomes-from-Androgen-Signaling\u2013directed-Therapy.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"300\" \/>\n\t<meta property=\"og:image:height\" content=\"250\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"CURC\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"CURC\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/carolinaurologicresearchcenter.com\/clinical-outcomes-androgen-signaling-directed-therapy-treatment-abiraterone-acetate-prednisone-patients-metastatic-castration-resistant-prostate-cancer-post-hoc\/\",\"url\":\"https:\/\/carolinaurologicresearchcenter.com\/clinical-outcomes-androgen-signaling-directed-therapy-treatment-abiraterone-acetate-prednisone-patients-metastatic-castration-resistant-prostate-cancer-post-hoc\/\",\"name\":\"Clinical Outcomes from Androgen Signaling\u2013directed Therapy after Treatment with Abiraterone Acetate and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302. With Dr. Neal Shore - Carolina Urologic Research Center - Myrtle Beach, SC\",\"isPartOf\":{\"@id\":\"https:\/\/carolinaurologicresearchcenter.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/carolinaurologicresearchcenter.com\/clinical-outcomes-androgen-signaling-directed-therapy-treatment-abiraterone-acetate-prednisone-patients-metastatic-castration-resistant-prostate-cancer-post-hoc\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/carolinaurologicresearchcenter.com\/clinical-outcomes-androgen-signaling-directed-therapy-treatment-abiraterone-acetate-prednisone-patients-metastatic-castration-resistant-prostate-cancer-post-hoc\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/carolinaurologicresearchcenter.com\/wp-content\/uploads\/7.13-Clinical-Outcomes-from-Androgen-Signaling\u2013directed-Therapy.jpg\",\"datePublished\":\"2017-07-13T12:22:50+00:00\",\"dateModified\":\"2017-07-13T12:24:25+00:00\",\"author\":{\"@id\":\"https:\/\/carolinaurologicresearchcenter.com\/#\/schema\/person\/1e494288987b949249fc933d8d93c363\"},\"breadcrumb\":{\"@id\":\"https:\/\/carolinaurologicresearchcenter.com\/clinical-outcomes-androgen-signaling-directed-therapy-treatment-abiraterone-acetate-prednisone-patients-metastatic-castration-resistant-prostate-cancer-post-hoc\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/carolinaurologicresearchcenter.com\/clinical-outcomes-androgen-signaling-directed-therapy-treatment-abiraterone-acetate-prednisone-patients-metastatic-castration-resistant-prostate-cancer-post-hoc\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/carolinaurologicresearchcenter.com\/clinical-outcomes-androgen-signaling-directed-therapy-treatment-abiraterone-acetate-prednisone-patients-metastatic-castration-resistant-prostate-cancer-post-hoc\/#primaryimage\",\"url\":\"https:\/\/carolinaurologicresearchcenter.com\/wp-content\/uploads\/7.13-Clinical-Outcomes-from-Androgen-Signaling\u2013directed-Therapy.jpg\",\"contentUrl\":\"https:\/\/carolinaurologicresearchcenter.com\/wp-content\/uploads\/7.13-Clinical-Outcomes-from-Androgen-Signaling\u2013directed-Therapy.jpg\",\"width\":300,\"height\":250},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/carolinaurologicresearchcenter.com\/clinical-outcomes-androgen-signaling-directed-therapy-treatment-abiraterone-acetate-prednisone-patients-metastatic-castration-resistant-prostate-cancer-post-hoc\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/carolinaurologicresearchcenter.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Clinical Outcomes from Androgen Signaling\u2013directed Therapy after Treatment with Abiraterone Acetate and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302. With Dr. Neal Shore\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/carolinaurologicresearchcenter.com\/#website\",\"url\":\"https:\/\/carolinaurologicresearchcenter.com\/\",\"name\":\"Carolina Urologic Research Center - Myrtle Beach, SC\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/carolinaurologicresearchcenter.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/carolinaurologicresearchcenter.com\/#\/schema\/person\/1e494288987b949249fc933d8d93c363\",\"name\":\"CURC\",\"url\":\"https:\/\/carolinaurologicresearchcenter.com\/author\/curc\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Clinical Outcomes from Androgen Signaling\u2013directed Therapy after Treatment with Abiraterone Acetate and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302. With Dr. Neal Shore - Carolina Urologic Research Center - Myrtle Beach, SC","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/carolinaurologicresearchcenter.com\/clinical-outcomes-androgen-signaling-directed-therapy-treatment-abiraterone-acetate-prednisone-patients-metastatic-castration-resistant-prostate-cancer-post-hoc\/","og_locale":"en_US","og_type":"article","og_title":"Clinical Outcomes from Androgen Signaling\u2013directed Therapy after Treatment with Abiraterone Acetate and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302. With Dr. Neal Shore - Carolina Urologic Research Center - Myrtle Beach, SC","og_description":"Click here to read more.","og_url":"https:\/\/carolinaurologicresearchcenter.com\/clinical-outcomes-androgen-signaling-directed-therapy-treatment-abiraterone-acetate-prednisone-patients-metastatic-castration-resistant-prostate-cancer-post-hoc\/","og_site_name":"Carolina Urologic Research Center - Myrtle Beach, SC","article_published_time":"2017-07-13T12:22:50+00:00","article_modified_time":"2017-07-13T12:24:25+00:00","og_image":[{"width":300,"height":250,"url":"https:\/\/carolinaurologicresearchcenter.com\/wp-content\/uploads\/7.13-Clinical-Outcomes-from-Androgen-Signaling\u2013directed-Therapy.jpg","type":"image\/jpeg"}],"author":"CURC","twitter_card":"summary_large_image","twitter_misc":{"Written by":"CURC"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/carolinaurologicresearchcenter.com\/clinical-outcomes-androgen-signaling-directed-therapy-treatment-abiraterone-acetate-prednisone-patients-metastatic-castration-resistant-prostate-cancer-post-hoc\/","url":"https:\/\/carolinaurologicresearchcenter.com\/clinical-outcomes-androgen-signaling-directed-therapy-treatment-abiraterone-acetate-prednisone-patients-metastatic-castration-resistant-prostate-cancer-post-hoc\/","name":"Clinical Outcomes from Androgen Signaling\u2013directed Therapy after Treatment with Abiraterone Acetate and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302. With Dr. Neal Shore - Carolina Urologic Research Center - Myrtle Beach, SC","isPartOf":{"@id":"https:\/\/carolinaurologicresearchcenter.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/carolinaurologicresearchcenter.com\/clinical-outcomes-androgen-signaling-directed-therapy-treatment-abiraterone-acetate-prednisone-patients-metastatic-castration-resistant-prostate-cancer-post-hoc\/#primaryimage"},"image":{"@id":"https:\/\/carolinaurologicresearchcenter.com\/clinical-outcomes-androgen-signaling-directed-therapy-treatment-abiraterone-acetate-prednisone-patients-metastatic-castration-resistant-prostate-cancer-post-hoc\/#primaryimage"},"thumbnailUrl":"https:\/\/carolinaurologicresearchcenter.com\/wp-content\/uploads\/7.13-Clinical-Outcomes-from-Androgen-Signaling\u2013directed-Therapy.jpg","datePublished":"2017-07-13T12:22:50+00:00","dateModified":"2017-07-13T12:24:25+00:00","author":{"@id":"https:\/\/carolinaurologicresearchcenter.com\/#\/schema\/person\/1e494288987b949249fc933d8d93c363"},"breadcrumb":{"@id":"https:\/\/carolinaurologicresearchcenter.com\/clinical-outcomes-androgen-signaling-directed-therapy-treatment-abiraterone-acetate-prednisone-patients-metastatic-castration-resistant-prostate-cancer-post-hoc\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/carolinaurologicresearchcenter.com\/clinical-outcomes-androgen-signaling-directed-therapy-treatment-abiraterone-acetate-prednisone-patients-metastatic-castration-resistant-prostate-cancer-post-hoc\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/carolinaurologicresearchcenter.com\/clinical-outcomes-androgen-signaling-directed-therapy-treatment-abiraterone-acetate-prednisone-patients-metastatic-castration-resistant-prostate-cancer-post-hoc\/#primaryimage","url":"https:\/\/carolinaurologicresearchcenter.com\/wp-content\/uploads\/7.13-Clinical-Outcomes-from-Androgen-Signaling\u2013directed-Therapy.jpg","contentUrl":"https:\/\/carolinaurologicresearchcenter.com\/wp-content\/uploads\/7.13-Clinical-Outcomes-from-Androgen-Signaling\u2013directed-Therapy.jpg","width":300,"height":250},{"@type":"BreadcrumbList","@id":"https:\/\/carolinaurologicresearchcenter.com\/clinical-outcomes-androgen-signaling-directed-therapy-treatment-abiraterone-acetate-prednisone-patients-metastatic-castration-resistant-prostate-cancer-post-hoc\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/carolinaurologicresearchcenter.com\/"},{"@type":"ListItem","position":2,"name":"Clinical Outcomes from Androgen Signaling\u2013directed Therapy after Treatment with Abiraterone Acetate and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302. With Dr. Neal Shore"}]},{"@type":"WebSite","@id":"https:\/\/carolinaurologicresearchcenter.com\/#website","url":"https:\/\/carolinaurologicresearchcenter.com\/","name":"Carolina Urologic Research Center - Myrtle Beach, SC","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/carolinaurologicresearchcenter.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/carolinaurologicresearchcenter.com\/#\/schema\/person\/1e494288987b949249fc933d8d93c363","name":"CURC","url":"https:\/\/carolinaurologicresearchcenter.com\/author\/curc\/"}]}},"_links":{"self":[{"href":"https:\/\/carolinaurologicresearchcenter.com\/wp-json\/wp\/v2\/posts\/929"}],"collection":[{"href":"https:\/\/carolinaurologicresearchcenter.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/carolinaurologicresearchcenter.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/carolinaurologicresearchcenter.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/carolinaurologicresearchcenter.com\/wp-json\/wp\/v2\/comments?post=929"}],"version-history":[{"count":0,"href":"https:\/\/carolinaurologicresearchcenter.com\/wp-json\/wp\/v2\/posts\/929\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/carolinaurologicresearchcenter.com\/wp-json\/wp\/v2\/media\/927"}],"wp:attachment":[{"href":"https:\/\/carolinaurologicresearchcenter.com\/wp-json\/wp\/v2\/media?parent=929"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/carolinaurologicresearchcenter.com\/wp-json\/wp\/v2\/categories?post=929"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/carolinaurologicresearchcenter.com\/wp-json\/wp\/v2\/tags?post=929"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}